Hypoglycaemic episodes
Subcutaneous insulin aspart showed no clear difference in hypoglycaemic episodes (N) Mean hospital stay: 3‐5 days compared with intravenous regular insulin (low certainty).
1 finding from 1 review
Perioperative death and strokes · people with recently symptomatic carotid artery stenosis
It is very uncertain whether very early cerebral revascularization changes stroke and Death < 30 days compared with delayed treatment (very low certainty).
1 finding from 1 review
Myocardial infarction (0 to 30 days) · people with recently symptomatic carotid artery stenosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of wounds healed · people presenting for surgery where healing of surgical wound planned to be by primary intention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of wounds healed · people presenting for surgery where healing of surgical wound planned to be by primary intention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Incidence of adverse events within 30 days of surgery · adults aged ≥ 18 years undergoing elective surgery at any surgical site
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Days missed from work or school · patients diagnosed with clinical and laboratory‐confirmed diagnosis of infectious mononucleosis (glandular fever)
1 finding from 1 review
Early infant death (0‐3 days) [ · pregnant women giving birth in non‐facility settings
Prophylactic oxytocin injection (delivered by community health… showed no clear difference in early infant death (0‐3 days) [ compared with control (no injection) (low certainty).
1 finding from 1 review
Length of hospital stay (days) Including the index admission for oesophagectomy (the hospital admission during which the oesophagectomy is performed) and any surgical complication‐related readmissions · patients with oesophageal cancer
1 finding from 1 review
Leukocytosis resolution time (days) · patients with septic abortion
1 finding from 1 review
Fever clearance time · patients with septic abortion
1 finding from 1 review
Neonatal mortality · very preterm infants at risk of intraventricular hemorrhage
It is very uncertain whether antithrombin changes neonatal mortality (all‐cause, < 28 days of age) compared with placebo (very low certainty).
1 finding from 1 review
Asthma symptoms · children with acute asthma
Children: higher dose/longer course showed no clear difference in asthma symptoms Symptom free by 7 days compared with lower dose/shorter course (moderate certainty).
1 finding from 1 review
Asthma symptoms Complete resolution by day 28 · Adults with acute asthma
Adults: higher dose/longer course showed no clear difference in asthma symptoms Complete resolution by day 28 compared with lower dose/shorter course (low certainty).
1 finding from 1 review
Asthma symptoms Returned to normal activities within 3 days · Adults with acute asthma
Adults: prednisolone showed no clear difference in asthma symptoms Returned to normal activities within 3 days compared with dexamethasone (low certainty).
1 finding from 1 review
Intervention not reported
30‐day mortality4 · individuals with atrial fibrillation who are undergoing cardiac surgery
The intervention showed no clear difference in 30‐day mortality4 (low certainty).
1 finding from 1 review
Numbers of working days or days lost related to influenza illness · Adults and elderly
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Initiation of oral feeding (days) · patients with the management of transient tachypnea of the newborn
1 finding from 1 review
Intervention not reported
Cognition (at 90 days): t‐MMSE score1 · adults with cognitive impairment/dementia and cognitively intact populations
1 finding from 1 review
Participants with ≥ 1 adverse event following a single dose, and after 3 to 5 days · adults with moderate or severe acute postoperative pain
1 finding from 1 review